References
- Byrd JC, Dodge RK, Carroll A, et al. Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administered. J Clin Oncol 1999;17:3767–3775.
- Specchia G, Albano F, Anelli L, et al. Insertions generating the 5’RUNX1/3’CBFA2T1 gene in acute myeloid leukemia cases show variable breakpoints. Genes Chromosomes Cancer 2004;41:86–91.
- Rucker FG, Bullinger L, Gribov A, et al. Molecular characterization of AML with ins(21;8)(q22;q22q22) reveals similarity to t(8;21) AML. Genes Chromosomes Cancer 2011;50:51–58.
- Kazama H, Aoyama M, Sameshima Y, et al. [Acute myelogenous leukemia with ins(21;8) expressing AML-1-MTG8 fusion transcript]. Rinsho Ketsueki 1996;37:1297–1302.
- Yamazaki E, Ogawa K, Harano H, et al. [Acute myelocytic leukemia with ins(21;8)(q22;q13q22) presenting with AML1/MTG8 chimeric mRNA]. Rinsho Ketsueki 2000;41:745–749.
- Bae SY, Kim JS, Ryeu BJ, et al. Acute myeloid leukemia (AML-M2) associated with variant t(8;21): report of three cases. Cancer Genet Cytogenet 2010;199:31–37.
- Ishii Y, Sashida G, Takaku TI, et al. Cryptic chromosomal anomaly in a patient with acute myeloid leukemia leading to AML1/ETO fusion with unfavorable prognostic factors. Cancer Genet Cytogenet 2005;160:94–95.
- Park TS, Song J, Lee KA, et al. Paracentric inversion-associated t(8;21) variant in de novo acute myelogenous leukemia: characteristic patterns of conventional cytogenetics, FISH, and multicolor banding analysis. Cancer Genet Cytogenet 2008;183:72–76.
- Harrison CJ, Radford-Weiss I, Ross F, et al. Fluorescence in situ hybridization analysis of masked (8;21)(q22;q22) translocations. Cancer Genet Cytogenet 1999;112:15–20.
- Grimwade D. Screening for core binding factor gene rearrangements in acute myeloid leukemia. Leukemia 2002;16: 964–969.